Cornercap Investment Counsel’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Cornercap Investment Counsel’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,673	Closed	-$262K	–	715
2024 Q1	$262K	Hold	16,673	–	–	0.04%	531
2023 Q4	$269K	Buy	16,673 +3,294	+25%	+$42K	0.04%	494
2023 Q3	$170K	Buy	+13,379	New	+$185K	0.03%	499

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Cornercap Investment Counsel's DCPH Position: Q2 2024 in Review

Cornercap Investment Counsel sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 16,673 shares — an estimated $262K sold.

Cornercap Investment Counsel first reported a position in DCPH in Q3 2023 and held it in 3 quarters. The position peaked at $269K in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Cornercap Investment Counsel reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Cornercap Investment Counsel sold 16,673 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $262K.
Cornercap Investment Counsel first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
Cornercap Investment Counsel's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $269K in Q4 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Cornercap Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.